Global TNF Inhibitors Market Insights, Forecast to 2029

Publisher Name :
Date: 14-Aug-2023
No. of pages: 94
Inquire Before Buying

TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflammation-causing substance. TNF inhibitor drugs are employed to treat inflammatory conditions such as rheumatoid arthritis and juvenile arthritis. Generally, in the healthy person, the TNF levels remain steady. However, in a patient with rheumatoid arthritis, the level of TNF is increasing which leads to more inflammation. TNF inhibitor drugs act as blockers for TNF substances. TNF alpha blockers are highly effective in the treatment of patients with active rheumatoid arthritis. These drugs are used in patients as a conventional second-line treatments.

Market Analysis and Insights: Global TNF Inhibitors Market

The global TNF Inhibitors market is projected to grow from US$ 42740 million in 2023 to US$ 45750 million by 2029, at a Compound Annual Growth Rate (CAGR) of 1.1% during the forecast period.

The adalimumab segment is likely to expand at a significant pace during the forecast period. The drug is effectively used in a broad range of pain management therapies and is widely available over the counter. Based on distribution channel, the TNF inhibitors market can be segmented into hospital pharmacy and retail pharmacy. The hospital pharmacy segment is likely to expand at a significant pace between 2017 and 2025, this is because patients with rheumatoid arthritis, arthritis give more preference to the hospitals for treatment. Increase in elderly population and rise in the prevalence of rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease are some of the factors that drive the TNF inhibitors market. According to the National Health Interview Survey, in 2016, almost 20% of the global population was reported to be suffering from chronic pain, with rheumatoid arthritis being one of the major reasons. Moreover, according to the Center for Disease Control and Prevention, by 2040, approximately 78 million (26%) of the U.S. adults are projected to have arthritis. Owing to this, the consumption of TNF inhibitor dugs is likely to increase rapidly in the near future. However, side-effects associated with the use of TNF inhibitor drugs such as skin irritation, flushing, headache, and abdominal pain are estimated to hinder the market in the next few years.

Report Includes

This report presents an overview of global market for TNF Inhibitors market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of TNF Inhibitors, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for TNF Inhibitors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the TNF Inhibitors revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global TNF Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for TNF Inhibitors revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Pfizer, Novartis, Boehringer Ingelheim, Amgen, BioPharma, Mochida Pharmaceutical and Hanall, etc.

By Company

- Pfizer

- Novartis

- Boehringer Ingelheim

- Amgen

- BioPharma

- Mochida Pharmaceutical

- Hanall

Segment by Type

- Monotherapy

- Combination Therapy

Segment by Application

- Skin Disease

- Ankylosing Spondylitis

- Gastrointestinal Disease

- Rheumatoid Arthritis

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of TNF Inhibitors in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of TNF Inhibitors companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, TNF Inhibitors revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global TNF Inhibitors Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TNF Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global TNF Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Skin Disease
1.3.3 Ankylosing Spondylitis
1.3.4 Gastrointestinal Disease
1.3.5 Rheumatoid Arthritis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global TNF Inhibitors Market Perspective (2018-2029)
2.2 Global TNF Inhibitors Growth Trends by Region
2.2.1 TNF Inhibitors Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 TNF Inhibitors Historic Market Size by Region (2018-2023)
2.2.3 TNF Inhibitors Forecasted Market Size by Region (2024-2029)
2.3 TNF Inhibitors Market Dynamics
2.3.1 TNF Inhibitors Industry Trends
2.3.2 TNF Inhibitors Market Drivers
2.3.3 TNF Inhibitors Market Challenges
2.3.4 TNF Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue TNF Inhibitors by Players
3.1.1 Global TNF Inhibitors Revenue by Players (2018-2023)
3.1.2 Global TNF Inhibitors Revenue Market Share by Players (2018-2023)
3.2 Global TNF Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of TNF Inhibitors, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global TNF Inhibitors Market Concentration Ratio
3.4.1 Global TNF Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TNF Inhibitors Revenue in 2022
3.5 Global Key Players of TNF Inhibitors Head office and Area Served
3.6 Global Key Players of TNF Inhibitors, Product and Application
3.7 Global Key Players of TNF Inhibitors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 TNF Inhibitors Breakdown Data by Type
4.1 Global TNF Inhibitors Historic Market Size by Type (2018-2023)
4.2 Global TNF Inhibitors Forecasted Market Size by Type (2024-2029)
5 TNF Inhibitors Breakdown Data by Application
5.1 Global TNF Inhibitors Historic Market Size by Application (2018-2023)
5.2 Global TNF Inhibitors Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America TNF Inhibitors Market Size (2018-2029)
6.2 North America TNF Inhibitors Market Size by Type
6.2.1 North America TNF Inhibitors Market Size by Type (2018-2023)
6.2.2 North America TNF Inhibitors Market Size by Type (2024-2029)
6.2.3 North America TNF Inhibitors Market Share by Type (2018-2029)
6.3 North America TNF Inhibitors Market Size by Application
6.3.1 North America TNF Inhibitors Market Size by Application (2018-2023)
6.3.2 North America TNF Inhibitors Market Size by Application (2024-2029)
6.3.3 North America TNF Inhibitors Market Share by Application (2018-2029)
6.4 North America TNF Inhibitors Market Size by Country
6.4.1 North America TNF Inhibitors Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America TNF Inhibitors Market Size by Country (2018-2023)
6.4.3 North America TNF Inhibitors Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe TNF Inhibitors Market Size (2018-2029)
7.2 Europe TNF Inhibitors Market Size by Type
7.2.1 Europe TNF Inhibitors Market Size by Type (2018-2023)
7.2.2 Europe TNF Inhibitors Market Size by Type (2024-2029)
7.2.3 Europe TNF Inhibitors Market Share by Type (2018-2029)
7.3 Europe TNF Inhibitors Market Size by Application
7.3.1 Europe TNF Inhibitors Market Size by Application (2018-2023)
7.3.2 Europe TNF Inhibitors Market Size by Application (2024-2029)
7.3.3 Europe TNF Inhibitors Market Share by Application (2018-2029)
7.4 Europe TNF Inhibitors Market Size by Country
7.4.1 Europe TNF Inhibitors Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe TNF Inhibitors Market Size by Country (2018-2023)
7.4.3 Europe TNF Inhibitors Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China TNF Inhibitors Market Size (2018-2029)
8.2 China TNF Inhibitors Market Size by Type
8.2.1 China TNF Inhibitors Market Size by Type (2018-2023)
8.2.2 China TNF Inhibitors Market Size by Type (2024-2029)
8.2.3 China TNF Inhibitors Market Share by Type (2018-2029)
8.3 China TNF Inhibitors Market Size by Application
8.3.1 China TNF Inhibitors Market Size by Application (2018-2023)
8.3.2 China TNF Inhibitors Market Size by Application (2024-2029)
8.3.3 China TNF Inhibitors Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia TNF Inhibitors Market Size (2018-2029)
9.2 Asia TNF Inhibitors Market Size by Type
9.2.1 Asia TNF Inhibitors Market Size by Type (2018-2023)
9.2.2 Asia TNF Inhibitors Market Size by Type (2024-2029)
9.2.3 Asia TNF Inhibitors Market Share by Type (2018-2029)
9.3 Asia TNF Inhibitors Market Size by Application
9.3.1 Asia TNF Inhibitors Market Size by Application (2018-2023)
9.3.2 Asia TNF Inhibitors Market Size by Application (2024-2029)
9.3.3 Asia TNF Inhibitors Market Share by Application (2018-2029)
9.4 Asia TNF Inhibitors Market Size by Region
9.4.1 Asia TNF Inhibitors Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia TNF Inhibitors Market Size by Region (2018-2023)
9.4.3 Asia TNF Inhibitors Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America TNF Inhibitors Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America TNF Inhibitors Market Size by Type
10.2.1 Middle East, Africa, and Latin America TNF Inhibitors Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America TNF Inhibitors Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America TNF Inhibitors Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America TNF Inhibitors Market Size by Application
10.3.1 Middle East, Africa, and Latin America TNF Inhibitors Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America TNF Inhibitors Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America TNF Inhibitors Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America TNF Inhibitors Market Size by Country
10.4.1 Middle East, Africa, and Latin America TNF Inhibitors Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America TNF Inhibitors Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America TNF Inhibitors Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer TNF Inhibitors Introduction
11.1.4 Pfizer Revenue in TNF Inhibitors Business (2018-2023)
11.1.5 Pfizer Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis TNF Inhibitors Introduction
11.2.4 Novartis Revenue in TNF Inhibitors Business (2018-2023)
11.2.5 Novartis Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim TNF Inhibitors Introduction
11.3.4 Boehringer Ingelheim Revenue in TNF Inhibitors Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen TNF Inhibitors Introduction
11.4.4 Amgen Revenue in TNF Inhibitors Business (2018-2023)
11.4.5 Amgen Recent Developments
11.5 BioPharma
11.5.1 BioPharma Company Details
11.5.2 BioPharma Business Overview
11.5.3 BioPharma TNF Inhibitors Introduction
11.5.4 BioPharma Revenue in TNF Inhibitors Business (2018-2023)
11.5.5 BioPharma Recent Developments
11.6 Mochida Pharmaceutical
11.6.1 Mochida Pharmaceutical Company Details
11.6.2 Mochida Pharmaceutical Business Overview
11.6.3 Mochida Pharmaceutical TNF Inhibitors Introduction
11.6.4 Mochida Pharmaceutical Revenue in TNF Inhibitors Business (2018-2023)
11.6.5 Mochida Pharmaceutical Recent Developments
11.7 Hanall
11.7.1 Hanall Company Details
11.7.2 Hanall Business Overview
11.7.3 Hanall TNF Inhibitors Introduction
11.7.4 Hanall Revenue in TNF Inhibitors Business (2018-2023)
11.7.5 Hanall Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global TNF Inhibitors Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global TNF Inhibitors Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global TNF Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global TNF Inhibitors Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global TNF Inhibitors Market Share by Region (2018-2023)
Table 8. Global TNF Inhibitors Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global TNF Inhibitors Market Share by Region (2024-2029)
Table 10. TNF Inhibitors Market Trends
Table 11. TNF Inhibitors Market Drivers
Table 12. TNF Inhibitors Market Challenges
Table 13. TNF Inhibitors Market Restraints
Table 14. Global TNF Inhibitors Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global TNF Inhibitors Revenue Share by Players (2018-2023)
Table 16. Global Top TNF Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TNF Inhibitors as of 2022)
Table 17. Global TNF Inhibitors Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by TNF Inhibitors Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of TNF Inhibitors, Headquarters and Area Served
Table 20. Global Key Players of TNF Inhibitors, Product and Application
Table 21. Global Key Players of TNF Inhibitors, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TNF Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global TNF Inhibitors Revenue Market Share by Type (2018-2023)
Table 25. Global TNF Inhibitors Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global TNF Inhibitors Revenue Market Share by Type (2024-2029)
Table 27. Global TNF Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global TNF Inhibitors Revenue Share by Application (2018-2023)
Table 29. Global TNF Inhibitors Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global TNF Inhibitors Revenue Share by Application (2024-2029)
Table 31. North America TNF Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America TNF Inhibitors Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America TNF Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America TNF Inhibitors Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America TNF Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America TNF Inhibitors Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America TNF Inhibitors Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe TNF Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe TNF Inhibitors Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe TNF Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe TNF Inhibitors Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe TNF Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe TNF Inhibitors Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe TNF Inhibitors Market Size by Country (2024-2029) & (US$ Million)
Table 45. China TNF Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 46. China TNF Inhibitors Market Size by Type (2024-2029) & (US$ Million)
Table 47. China TNF Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 48. China TNF Inhibitors Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia TNF Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia TNF Inhibitors Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia TNF Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia TNF Inhibitors Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia TNF Inhibitors Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia TNF Inhibitors Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia TNF Inhibitors Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America TNF Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America TNF Inhibitors Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America TNF Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America TNF Inhibitors Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America TNF Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America TNF Inhibitors Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America TNF Inhibitors Market Size by Country (2024-2029) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer TNF Inhibitors Product
Table 66. Pfizer Revenue in TNF Inhibitors Business (2018-2023) & (US$ Million)
Table 67. Pfizer Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis TNF Inhibitors Product
Table 71. Novartis Revenue in TNF Inhibitors Business (2018-2023) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Boehringer Ingelheim Company Details
Table 74. Boehringer Ingelheim Business Overview
Table 75. Boehringer Ingelheim TNF Inhibitors Product
Table 76. Boehringer Ingelheim Revenue in TNF Inhibitors Business (2018-2023) & (US$ Million)
Table 77. Boehringer Ingelheim Recent Developments
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen TNF Inhibitors Product
Table 81. Amgen Revenue in TNF Inhibitors Business (2018-2023) & (US$ Million)
Table 82. Amgen Recent Developments
Table 83. BioPharma Company Details
Table 84. BioPharma Business Overview
Table 85. BioPharma TNF Inhibitors Product
Table 86. BioPharma Revenue in TNF Inhibitors Business (2018-2023) & (US$ Million)
Table 87. BioPharma Recent Developments
Table 88. Mochida Pharmaceutical Company Details
Table 89. Mochida Pharmaceutical Business Overview
Table 90. Mochida Pharmaceutical TNF Inhibitors Product
Table 91. Mochida Pharmaceutical Revenue in TNF Inhibitors Business (2018-2023) & (US$ Million)
Table 92. Mochida Pharmaceutical Recent Developments
Table 93. Hanall Company Details
Table 94. Hanall Business Overview
Table 95. Hanall TNF Inhibitors Product
Table 96. Hanall Revenue in TNF Inhibitors Business (2018-2023) & (US$ Million)
Table 97. Hanall Recent Developments
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global TNF Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global TNF Inhibitors Market Share by Type: 2022 VS 2029
Figure 3. Monotherapy Features
Figure 4. Combination Therapy Features
Figure 5. Global TNF Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global TNF Inhibitors Market Share by Application: 2022 VS 2029
Figure 7. Skin Disease Case Studies
Figure 8. Ankylosing Spondylitis Case Studies
Figure 9. Gastrointestinal Disease Case Studies
Figure 10. Rheumatoid Arthritis Case Studies
Figure 11. Others Case Studies
Figure 12. TNF Inhibitors Report Years Considered
Figure 13. Global TNF Inhibitors Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global TNF Inhibitors Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global TNF Inhibitors Market Share by Region: 2022 VS 2029
Figure 16. Global TNF Inhibitors Market Share by Players in 2022
Figure 17. Global Top TNF Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TNF Inhibitors as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by TNF Inhibitors Revenue in 2022
Figure 19. North America TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America TNF Inhibitors Market Share by Type (2018-2029)
Figure 21. North America TNF Inhibitors Market Share by Application (2018-2029)
Figure 22. North America TNF Inhibitors Market Share by Country (2018-2029)
Figure 23. United States TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe TNF Inhibitors Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe TNF Inhibitors Market Share by Type (2018-2029)
Figure 27. Europe TNF Inhibitors Market Share by Application (2018-2029)
Figure 28. Europe TNF Inhibitors Market Share by Country (2018-2029)
Figure 29. Germany TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China TNF Inhibitors Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China TNF Inhibitors Market Share by Type (2018-2029)
Figure 37. China TNF Inhibitors Market Share by Application (2018-2029)
Figure 38. Asia TNF Inhibitors Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia TNF Inhibitors Market Share by Type (2018-2029)
Figure 40. Asia TNF Inhibitors Market Share by Application (2018-2029)
Figure 41. Asia TNF Inhibitors Market Share by Region (2018-2029)
Figure 42. Japan TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America TNF Inhibitors Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America TNF Inhibitors Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America TNF Inhibitors Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America TNF Inhibitors Market Share by Country (2018-2029)
Figure 52. Brazil TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries TNF Inhibitors Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in TNF Inhibitors Business (2018-2023)
Figure 59. Novartis Revenue Growth Rate in TNF Inhibitors Business (2018-2023)
Figure 60. Boehringer Ingelheim Revenue Growth Rate in TNF Inhibitors Business (2018-2023)
Figure 61. Amgen Revenue Growth Rate in TNF Inhibitors Business (2018-2023)
Figure 62. BioPharma Revenue Growth Rate in TNF Inhibitors Business (2018-2023)
Figure 63. Mochida Pharmaceutical Revenue Growth Rate in TNF Inhibitors Business (2018-2023)
Figure 64. Hanall Revenue Growth Rate in TNF Inhibitors Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs